Abstract

Inflammatory bowel disease (IBD) is a chronic non-specific intestinal inflammatory disease, with unknown aetiology. There is a tendency to relapse throughout the life of patients with IBD and the severe cases cannot be cured. Early treatment is based on drugs, and some severe patients require surgical intervention later. In recent years, mesenchymal stem cells (MSCs) have been widely used in the experimental research of IBD treatment due to their multi-directional differentiation potential, immune regulation and tissue repair function, and it has a certain theoretical basis. In some clinical trials of MSCs for the treatment of IBD, there no serious complications have been reported and a certain therapeutic effect has been found. Currently, such stem cell therapy is not a standard of treatment regimen for IBD. However, it may potentially become a new option, especially for the IBD which is refractory or complicated with anal fistula. The purpose of this review article is to summarize the basic characteristics of MSCs, demonstrate the mechanism and application of MSCs in the therapy of IBD and prospect its trend in the future. Key words: Mesenchymal stem cells; Inflammatory bowel disease; Mechanism; Prospects

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.